✦ LIBER ✦

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial: a rebuttal

✍ Scribed by J. P. PATEL; B. GREEN; R. K. PATEL; J. G. DAVIES; R. ARYA

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Population pharmacokinetic analysis of t

✍ K.-H. LIESENFELD; T. LEHR; C. DANSIRIKUL; P. A. REILLY; S. J. CONNOLLY; M. D. EZ 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Population pharmacokinetic analysis of t

✍ K.-H. LIESENFELD; T. LEHR; C. DANSIRIKUL; P. A. REILLY; S. J. CONNOLLY; M. D. EZ 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Dabigatran compared with warfarin in pat

✍ Hans-Christoph Diener; Stuart J Connolly; Michael D Ezekowitz; Lars Wallentin; P 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 177 KB

Oral direct thrombin inhibitor AZD0837 f

✍ Gregory Y.H. Lip; Lars H. Rasmussen; S. Bertil Olsson; Sofia Zetterstrand; Chris 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 659 KB